Table 1.
Patient demographics.
| Congenital |
Multisystemic |
Ocular |
Other |
Toxoplasmic Encephalitis |
Unspecified |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Visits | % | Visits | % | Visits | % | Visits | % | Visits | % | Visits | % | |
| Gender | ||||||||||||
| Female | 207 | 66.1% | 29 | 41.4% | 1,079 | 49.8% | 611 | 41.0% | 540 | 35.1% | 2,217 | 47.2% |
| Male | 106 | 33.9% | 41 | 58.6% | 1,081 | 49.9% | 877 | 58.8% | 997 | 64.9% | 2,472 | 52.6% |
| Missing/Unknown | 0 | 0.0% | 0 | 0.0% | 5 | 0.2% | 3 | 0.2% | 0 | 0.0% | 8 | 0.2% |
| Age Group | ||||||||||||
| <18 years | 289 | 92.3% | 2 | 2.9% | 143 | 6.6% | 25 | 1.7% | 24 | 1.6% | 92 | 2.0% |
| 18–29 years | 8 | 2.6% | 8 | 11.4% | 287 | 13.3% | 128 | 8.6% | 107 | 7.0% | 576 | 12.3% |
| 30–39 years | 7 | 2.2% | 18 | 25.7% | 355 | 16.4% | 383 | 25.7% | 349 | 22.7% | 939 | 20.0% |
| 40–49 years | 3 | 1.0% | 7 | 10.0% | 263 | 12.1% | 437 | 29.3% | 562 | 36.6% | 906 | 19.3% |
| 50–59 years | 1 | 0.3% | 24 | 34.3% | 305 | 14.1% | 274 | 18.4% | 356 | 23.2% | 820 | 17.5% |
| 60–69 years | 1 | 0.3% | 3 | 4.3% | 355 | 16.4% | 143 | 9.6% | 90 | 5.9% | 911 | 19.4% |
| 70–79 years | 4 | 1.3% | 6 | 8.6% | 282 | 13.0% | 74 | 5.0% | 38 | 2.5% | 385 | 8.2% |
| 80–89 years | 0 | 0.0% | 1 | 1.4% | 159 | 7.3% | 23 | 1.5% | 8 | 0.5% | 52 | 1.1% |
| ≥90 years | 0 | 0.0% | 1 | 1.4% | 13 | 0.6% | 3 | 0.2% | 3 | 0.2% | 12 | 0.3% |
| Missing/Unknown | 0.0% | 3 | 0.1% | 1 | 0.1% | 4 | 0.1% | |||||
| Age in Years (Mean±SD) | 4.1 | 12.1 | 46.5 | 16.5 | 49.5 | 20.7 | 45.4 | 14.3 | 44.8 | 12.0 | 47.9 | 16.3 |
| Comorbidities | ||||||||||||
| History of transplant | 0 | 0.0% | 14 | 20.0% | 85 | 3.9% | 53 | 3.6% | 61 | 4.0% | 1,641 | 34.9% |
| Human Immunodeficiency Virus | 40 | 12.8% | 37 | 52.9% | 195 | 9.0% | 1,037 | 69.6% | 1,161 | 75.5% | 1,350 | 28.7% |
| Myocardial infarction | 0 | 0.0% | 6 | 8.6% | 96 | 4.4% | 35 | 2.3% | 16 | 1.0% | 196 | 4.2% |
| Congestive heart failure | 1 | 0.3% | 13 | 18.6% | 133 | 6.1% | 59 | 4.0% | 47 | 3.1% | 541 | 11.5% |
| Peripheral vascular disease | 0 | 0.0% | 3 | 4.3% | 68 | 3.1% | 25 | 1.7% | 8 | 0.5% | 230 | 4.9% |
| Cerebrovascular disease | 10 | 3.2% | 8 | 11.4% | 154 | 7.1% | 178 | 11.9% | 180 | 11.7% | 510 | 10.9% |
| Dementia | 0 | 0.0% | 0 | 0.0% | 12 | 0.6% | 10 | 0.7% | 10 | 0.7% | 38 | 0.8% |
| Chronic pulmonary disease | 5 | 1.6% | 11 | 15.7% | 293 | 13.5% | 249 | 16.7% | 164 | 10.7% | 1,358 | 28.9% |
| Rheumatic disease | 0 | 0.0% | 2 | 2.9% | 25 | 1.2% | 24 | 1.6% | 30 | 2.0% | 211 | 4.5% |
| Peptic ulcer disease | 0 | 0.0% | 3 | 4.3% | 45 | 2.1% | 39 | 2.6% | 17 | 1.1% | 150 | 3.2% |
| Mild liver disease | 0 | 0.0% | 0 | 0.0% | 9 | 0.4% | 20 | 1.3% | 8 | 0.5% | 66 | 1.4% |
| Diabetes without chronic complication | 1 | 0.3% | 6 | 8.6% | 284 | 13.1% | 231 | 15.5% | 140 | 9.1% | 1,505 | 32.0% |
| Diabetes with chronic complication | 0 | 0.0% | 1 | 1.4% | 106 | 4.9% | 32 | 2.1% | 8 | 0.5% | 100 | 2.1% |
| Hemiplegia or paraplegia | 4 | 1.3% | 5 | 7.1% | 64 | 3.0% | 163 | 10.9% | 168 | 10.9% | 175 | 3.7% |
| Renal disease | 3 | 1.0% | 15 | 21.4% | 193 | 8.9% | 204 | 13.7% | 170 | 11.1% | 727 | 15.5% |
| Any malignancy | 4 | 1.3% | 18 | 25.7% | 207 | 9.6% | 197 | 13.2% | 209 | 13.6% | 488 | 10.4% |
| Moderate or severe liver disease | 0 | 0.0% | 0 | 0.0% | 5 | 0.2% | 9 | 0.6% | 6 | 0.4% | 43 | 0.9% |
| Metastatic solid tumor | 0 | 0.0% | 2 | 2.9% | 41 | 1.9% | 24 | 1.6% | 24 | 1.6% | 105 | 2.2% |
| Charlson Comorbidity Index (Mean±SD) | 0.9 | 2.0 | 5.3 | 3.2 | 1.8 | 3.0 | 5.8 | 3.5 | 5.9 | 3.2 | 3.9 | 3.4 |
| Discharge Destination | ||||||||||||
| Home | 189 | 60.4% | 44 | 62.9% | 1,757 | 81.2% | 981 | 65.8% | 1,150 | 74.8% | 4,094 | 87.2% |
| Home Health | 5 | 1.6% | 2 | 2.9% | 63 | 2.9% | 88 | 5.9% | 84 | 5.5% | 46 | 1.0% |
| Intermediate care/Skilled nursing/Long term care facility | 0 | 0.0% | 5 | 7.1% | 46 | 2.1% | 110 | 7.4% | 81 | 5.3% | 78 | 1.7% |
| Transfer to another facility | 5 | 1.6% | 1 | 1.4% | 11 | 0.5% | 22 | 1.5% | 18 | 1.2% | 31 | 0.7% |
| Expired | 0 | 0.0% | 2 | 2.9% | 9 | 0.4% | 45 | 3.0% | 32 | 2.1% | 19 | 0.4% |
| Rehabilitation | 1 | 0.3% | 1 | 1.4% | 2 | 0.1% | 27 | 1.8% | 23 | 1.5% | 12 | 0.3% |
| Left against medical advice | 0 | 0.0% | 0 | 0.0% | 7 | 0.3% | 28 | 1.9% | 9 | 0.6% | 18 | 0.4% |
| Other | 0 | 0.0% | 0 | 0.0% | 11 | 0.5% | 7 | 0.5% | 14 | 0.9% | 59 | 1.3% |
| Transfer to other type of facility | 5 | 1.6% | 2 | 2.9% | 5 | 0.2% | 13 | 0.9% | 9 | 0.6% | 10 | 0.2% |
| Hospice | 0 | 0.0% | 2 | 2.9% | 8 | 0.4% | 49 | 3.3% | 29 | 1.9% | 13 | 0.3% |
| Missing/Unknown | 108 | 34.5% | 11 | 15.7% | 246 | 11.4% | 121 | 8.1% | 88 | 5.7% | 317 | 6.7% |
| Payer | ||||||||||||
| Commercial | 73 | 23.3% | 11 | 15.7% | 615 | 28.4% | 215 | 14.4% | 242 | 15.7% | 815 | 17.4% |
| Medicaid | 142 | 45.4% | 19 | 27.1% | 224 | 10.3% | 412 | 27.6% | 441 | 28.7% | 701 | 14.9% |
| Medicare | 8 | 2.6% | 25 | 35.7% | 806 | 37.2% | 370 | 24.8% | 301 | 19.6% | 1,364 | 29.0% |
| Other | 8 | 2.6% | 4 | 5.7% | 260 | 12.0% | 153 | 10.3% | 197 | 12.8% | 348 | 7.4% |
| Unknown | 82 | 26.2% | 11 | 15.7% | 260 | 12.0% | 341 | 22.9% | 356 | 23.2% | 1,469 | 31.3% |
| Hospital Bed Size | ||||||||||||
| <100 Beds | 43 | 13.7% | 0 | 0.0% | 61 | 2.8% | 52 | 3.5% | 24 | 1.6% | 96 | 2.0% |
| 100–199 Beds | 17 | 5.4% | 4 | 5.7% | 212 | 9.8% | 119 | 8.0% | 78 | 5.1% | 285 | 6.1% |
| 200–299 Beds | 22 | 7.0% | 1 | 1.4% | 139 | 6.4% | 88 | 5.9% | 47 | 3.1% | 193 | 4.1% |
| 300–499 Beds | 63 | 20.1% | 18 | 25.7% | 680 | 31.4% | 517 | 34.7% | 376 | 24.5% | 965 | 20.5% |
| ≥500 Beds | 168 | 53.7% | 47 | 67.1% | 1,073 | 49.6% | 715 | 48.0% | 1,012 | 65.8% | 3,158 | 67.2% |
| Hospital Teaching Status | ||||||||||||
| Non-teaching | 79 | 25.2% | 10 | 14.3% | 427 | 19.7% | 401 | 26.9% | 218 | 14.2% | 667 | 14.2% |
| Teaching | 224 | 71.6% | 60 | 85.7% | 1,738 | 80.3% | 1,090 | 73.1% | 1,319 | 85.8% | 4,030 | 85.8% |